Dachaigh › Ailse Endometrial › Sgìre Cholumbia › Washington
Sgrùdaidhean clionaigeach Ailse Endometrial ann an Washington, DC
Tha 18 sgrùdaidhean airson Ailse Endometrial a’ lorg phàirtichean aig làraichean ann agus timcheall air Washington (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
A’ fastadhÌre 3
- MedStar Washington Hospital Center, Washington D.C.
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
A’ fastadhÌre 2
- Walter Reed National Military Medical Center, Bethesda · 7 mìle air falbh
- National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
A’ fastadhÌre 2
- National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
A’ fastadhÌre 1
- Georgetown University Medical Center, Washington D.C.
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
A’ fastadhÌre 3
- MedStar Washington Hospital Center, Washington D.C.
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
A’ fastadhÌre 3
- MedStar Washington Hospital Center ( Site 5005), Washington D.C.
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
A’ fastadhÌre 3
- MedStar Washington Hospital, Washington D.C.
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
A’ fastadhÌre 3
- Research Site, Silver Spring · 7 mìle air falbh
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
A’ fastadhÌre 1
- Georgetown University Medical Center, Washington D.C.
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
A’ fastadhÌre 1/2
- Children's National Medical Center, Washington D.C.
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
A’ fastadhÌre 1
- Normunity Investigational Site, Washington D.C.
FOG-001 in Locally Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1/2
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
A’ fastadhÌre 1/2
- National Institutes of Health, Bethesda · 7 mìle air falbh
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
A’ fastadhÌre 3
- Research Site, Washington D.C.
- Research Site, Silver Spring · 7 mìle air falbh
Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer
A’ fastadhÌre 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A’ fastadhSgrùdadh amharc
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mìle air falbh
- Massive Bio SYNERGY-AI site, Bethesda · 7 mìle air falbh
BP1001-A in Patients With Advanced or Recurrent Solid Tumors
A’ fastadhÌre 1
- Holy Cross Hospital, Silver Spring · 7 mìle air falbh
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
A’ fastadhÌre 2/3
- Maryland Oncology Hematology, P.A., Silver Spring · 7 mìle air falbh
Sgrùdaidhean Ailse Endometrial ann am bailtean eile
- Houston, TX68 sgrùdaidhean
- New York City, NY52 sgrùdaidhean
- Boston, MA50 sgrùdaidhean
- Arlington, VA39 sgrùdaidhean
- Nashville, TN38 sgrùdaidhean
- Los Angeles, CA34 sgrùdaidhean
- St. Louis, MO29 sgrùdaidhean
- Philadelphia, PA28 sgrùdaidhean
- San Antonio, TX27 sgrùdaidhean
- Columbus, OH25 sgrùdaidhean
- Oklahoma City, OK25 sgrùdaidhean
- Chicago, IL25 sgrùdaidhean
Sgrùdaidhean eile ann an Washington
- Aillse (gach seòrsa)58 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag55 sgrùdaidhean
- Aillse a' bhroilleach46 sgrùdaidhean
- Ailse metastatach43 sgrùdaidhean
- Ailseachadh nan Sgamhan41 sgrùdaidhean
- Aillse Prostata38 sgrùdaidhean
- Obesity33 sgrùdaidhean
- Aillse colorectal29 sgrùdaidhean
- Galarachd Cardiovasculach28 sgrùdaidhean
- Aillse sa bhlaire26 sgrùdaidhean
- Leukemia myeloid geur24 sgrùdaidhean
- Cancer Ovarian23 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.